Cite
APA Citation
Charles‐Schoeman, C., DeMasi, R., Valdez, H., Soma, K., Hwang, L., Boy, M. G., Biswas, P., & McInnes, I. B. (2019). risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis. Arthritis & rheumatology, 71(9), 1450–1459. http://access.bl.uk/ark:/81055/vdc_100091288709.0x000008